Movatterモバイル変換


[0]ホーム

URL:


US2671451A - Remedial pill - Google Patents

Remedial pill
Download PDF

Info

Publication number
US2671451A
US2671451AUS293731AUS29373152AUS2671451AUS 2671451 AUS2671451 AUS 2671451AUS 293731 AUS293731 AUS 293731AUS 29373152 AUS29373152 AUS 29373152AUS 2671451 AUS2671451 AUS 2671451A
Authority
US
United States
Prior art keywords
pill
remedial
substance
magnetically attractable
ulcer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US293731A
Inventor
Stephen J Bolger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IndividualfiledCriticalIndividual
Priority to US293731ApriorityCriticalpatent/US2671451A/en
Application grantedgrantedCritical
Publication of US2671451ApublicationCriticalpatent/US2671451A/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Description

5. J. BOLGER REMEDIAL PILL March 9, 1954 Filed June 16, 1952 INVENTOR fiephen' JLBO {9 mauw ATTORNEY Patented Mar. 9, 1954 UNITED STATES PATENT OFFICE 3 Claims.
The present invention relates to remedies and more particularly to pill-type remedies and a method of treating internal disorders.
In localized disorders of the alimentary canal, particularly ulcers, it is very diflicult to apply a remedy to the affected spot for the reason that there is a constant flow through the canal caused by the normal digestive processes. Any remedy in the form of a tablet or pill is therefore quickly washed past the affected spot and consequently has very little or no remedial efiect. There are known remedies which, if they could be made to stop at or near the affected spot, would slowly dissolve, with a highly beneficial effect.
The objects of this invention are, therefore, to provide an efiicacious method of treating such localized internal disorders, and more specifically to provide a special type of pill to be used in connection with the method.
Illustrative embodiments of the invention are shown in the accompanying drawing, wherein:
Figure 1 is a front view of a human torso showing parts of the alimentary canal in cutaway view;
Figure 2 is a similar view of a human torso showing parts of the alimentary canal in dotted lines and illustrating the first step in practicing my new method;
Figure 3 is a cutaway view of a part of the alimentary canal showing the esophagus, the stomach, the pylorus and the duodenum, which view illustrates another step in the practice of my new method;
Figure 4 is a central sectional view through a spherical pill made according to the invention; and
Figure 5 is a. perspective view of a lozenge or tablet form of the pill.
Referring now in detail to these drawings, Figures 1 and 2 show the human torso generally designated l and parts of the alimentary canal comprising the esophagus II, the stomach l2, and the intestines which are generally designated I3.
Any part of the alimentary canal might be locally affected as by an ulcer, and if so afiected could be treated according to my new method. However for the purpose oi illustration I have shown in Figure 3 the pylorus ll affected by an ulcer I 5.
In treating the ulcer according to my method, I first apply to the exterior of the human torso nearest the ulcer a powerful magnet l6 (see Figure 2) here shown as a bar magnet secured Cir in position as by means of adhesive tape II. It will be understood that any other form of magnet such as an electromagnet might be used in place of the magnet IB. Next I administer to the patient, who is preferably in a reclining position, a special pill generally designated 18 in Figure 3. This special pill forms a part of my invention, and comprises a body of the prescribed remedial substance having a, magnetically attractable metallic element associated therewith. The pill illustrated in Figure 4 is of spherical form, having a body 19 of the remedial substance and a spherical core 28 of iron or other magnetically attractable metal. The pill shown in Figure 5 is similar, comprising a lozenge-type body 2| of the remedial substance and a core 22 of magnetically attractable metal.
When the pill has passed through the alimentary canal to a point at or near the ulcer IE, it is halted in its passage by the magnet "S, whereupon the pill slowly dissolves in the immediate vicinity of the ulcer with beneficial efiects thereon. When the pill has completely dissolved the magnet IB is removed from the patient's body and the metallic core of the pill passes harmlessly therethrough.
While I have described but one application of my invention, and indicated others, it will be understood that the method and the form of pill might find numerous other applications falllng within the scope of the following claims.
I claim:
1. A remedial pill comprising a remedial substance which is soluble in the human body and a. magnetically attractable metallic element associated with said substance.
2. A remedial pill having a core of magnetically attractable metal encased in a remedial substance which is soluble in the human body.
3. A spherical remedial pill having a spherical core of magnetically attractable metal.
STEPHEN J. BOLGER.
References Cited in the file of this patent UNITED STATES PATENTS Number Name Date 1,505,209 Leach et al Aug. 19, 1924 2,483,098 Millard Sept. 27, 1949 2,518,758 Cook Aug. 15, 1950 FOREIGN PATENTS Number Country Date 485,378 Great Britain May 18, 1938

Claims (1)

1. A REMEDIAL PILL COMPRISING A REMEDIAL SUBSTANCE WHICH IS SOLUBLE IN THE HUMAN BODY AND A MAGNETICALLY ATTRACTABLE METALLIC ELEMENT ASSOCIATED WITH SAID SUBSTANCE.
US293731A1952-06-161952-06-16Remedial pillExpired - LifetimeUS2671451A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US293731AUS2671451A (en)1952-06-161952-06-16Remedial pill

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US293731AUS2671451A (en)1952-06-161952-06-16Remedial pill

Publications (1)

Publication NumberPublication Date
US2671451Atrue US2671451A (en)1954-03-09

Family

ID=23130333

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US293731AExpired - LifetimeUS2671451A (en)1952-06-161952-06-16Remedial pill

Country Status (1)

CountryLink
US (1)US2671451A (en)

Cited By (68)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2863458A (en)*1957-09-041958-12-09Michael T ModnyVein stripper and a method of stripping veins
US2921584A (en)*1954-12-171960-01-19Honeywell Regulator CoVessel occluder
US2971916A (en)*1957-01-301961-02-14Ncr CoMicroscopic capsules containing magnetizable material
US3042616A (en)*1958-08-261962-07-03IbmProcess of preparing magnetic ink
US3056724A (en)*1956-11-051962-10-02Commw Scient Ind Res OrgTherapeutic pellets for ruminants
US3057344A (en)*1957-05-211962-10-09Abella Carlos AlbertoCapsule for the study of the digestive tract and method of using the same
US3118439A (en)*1957-04-091964-01-21Perrenoud Jean-PierreDiagnostic and medicating capsule and the method of use
US3146169A (en)*1960-01-211964-08-25Burroughs Wellcome CoPharmaceutical formulations and their manufacture
US3421210A (en)*1964-08-051969-01-14Nitroglycerin AbMethod for the manufacture of the fuse head element of electric fuses
US3474777A (en)*1966-02-101969-10-28Amp IncMethod of administering therapeutic agents
US3592185A (en)*1967-04-181971-07-13Yeda Res & DevFerromagnetic contrast media and method of use
US3608549A (en)*1970-01-151971-09-28Merrill Edward WilsonMethod of administering drugs and capsule therefor
US4030499A (en)*1974-12-301977-06-21Louis BucaloMethod and apparatus for providing living beings with absorbable implants
EP0000667A1 (en)*1977-08-011979-02-07Northwestern UniversityIntravascularly-administrable, magnetically-localizable biodegradable carrier and process for its preparation
US4162679A (en)*1976-09-281979-07-31Reenstierna Erik G BMethod and device for the implantation of one or more pacemaker electrodes in a heart
US4247406A (en)*1979-04-231981-01-27Widder Kenneth JIntravascularly-administrable, magnetically-localizable biodegradable carrier
EP0042249A2 (en)1980-06-131981-12-23Northwestern UniversityMagnetically-localizable, biodegradable lipid microspheres
US4830855A (en)*1987-11-131989-05-16Landec Labs, Inc.Temperature-controlled active agent dispenser
US4878905A (en)*1986-02-071989-11-07Blass Karl GGastrointestinal module: a nonsurgical implant
EP0409893A4 (en)*1988-04-011991-03-13Walter Whitson FischmanMagnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
US5079006A (en)*1987-07-151992-01-07Aprex CorporationPharmaceutical compositions containing a magnetically detectable material
US5162037A (en)*1988-04-011992-11-10Whitson Laboratories, Inc.Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
US5401516A (en)*1992-12-211995-03-28Emisphere Technologies, Inc.Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US5443841A (en)*1992-06-151995-08-22Emisphere Technologies, Inc.Proteinoid microspheres and methods for preparation and use thereof
US5447728A (en)*1992-06-151995-09-05Emisphere Technologies, Inc.Desferrioxamine oral delivery system
US5529568A (en)*1994-03-181996-06-25Surgery Futures Research, Inc.Magnetic operating table
US5541155A (en)*1994-04-221996-07-30Emisphere Technologies, Inc.Acids and acid salts and their use in delivery systems
US5578323A (en)*1992-06-151996-11-26Emisphere Technologies, Inc.Proteinoid carriers and methods for preparation and use thereof
US5629020A (en)*1994-04-221997-05-13Emisphere Technologies, Inc.Modified amino acids for drug delivery
US5643957A (en)*1993-04-221997-07-01Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5650386A (en)*1995-03-311997-07-22Emisphere Technologies, Inc.Compositions for oral delivery of active agents
US5667806A (en)*1995-06-071997-09-16Emisphere Technologies, Inc.Spray drying method and apparatus
US5693338A (en)*1994-09-291997-12-02Emisphere Technologies, Inc.Diketopiperazine-based delivery systems
US5709861A (en)*1993-04-221998-01-20Emisphere Technologies, Inc.Compositions for the delivery of antigens
US5714167A (en)*1992-06-151998-02-03Emisphere Technologies, Inc.Active agent transport systems
US5750147A (en)*1995-06-071998-05-12Emisphere Technologies, Inc.Method of solubilizing and encapsulating itraconazole
US5766633A (en)*1993-04-221998-06-16Emisphere Technologies, Inc.Oral drug delivery compositions and methods
USRE35862E (en)*1986-08-181998-07-28Emisphere Technologies, Inc.Delivery systems for pharmacological agents encapsulated with proteinoids
US5792451A (en)*1994-03-021998-08-11Emisphere Technologies, Inc.Oral drug delivery compositions and methods
US5804688A (en)*1997-02-071998-09-08Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5811127A (en)*1992-06-151998-09-22Emisphere Technologies, Inc.Desferrioxamine oral delivery system
US5820881A (en)*1995-04-281998-10-13Emisphere Technologies, Inc.Microspheres of diamide-dicarboxylic acids
US5824345A (en)*1995-06-071998-10-20Emisphere Technologies, Inc.Fragrances and flavorants
US5863944A (en)*1997-04-301999-01-26Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5866536A (en)*1995-03-311999-02-02Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5876710A (en)*1997-02-071999-03-02Emisphere Technologies Inc.Compounds and compositions for delivering active agents
US5879681A (en)*1997-02-071999-03-09Emisphere Technolgies Inc.Compounds and compositions for delivering active agents
US5939381A (en)*1997-02-071999-08-17Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5958457A (en)*1993-04-221999-09-28Emisphere Technologies, Inc.Compositions for the delivery of antigens
US5962710A (en)*1997-05-091999-10-05Emisphere Technologies, Inc.Method of preparing salicyloylamino acids
US5965121A (en)*1995-03-311999-10-12Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5989539A (en)*1995-03-311999-11-23Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5990166A (en)*1997-02-071999-11-23Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6001347A (en)*1995-03-311999-12-14Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6051258A (en)*1995-06-072000-04-18Emisphere Technologies, Inc.Proteinoid emulsions and methods for preparation and use thereof
US6060513A (en)*1997-02-072000-05-09Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6071510A (en)*1995-03-312000-06-06Emisphere Technologies, Inc.Modified amino acids and compositions comprising the same for delivering active agents
US6084112A (en)*1995-09-112000-07-04Emisphere Technologies, Inc.Method for preparing ω-aminoalkanoic acid derivatives from cycloalkanones
US6090958A (en)*1995-03-312000-07-18Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6099856A (en)*1992-06-152000-08-08Emisphere Technologies, Inc.Active agent transport systems
US6221367B1 (en)1992-06-152001-04-24Emisphere Technologies, Inc.Active agent transport systems
US6242495B1 (en)1997-02-072001-06-05Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6331318B1 (en)1994-09-302001-12-18Emisphere Technologies Inc.Carbon-substituted diketopiperazine delivery systems
US6375983B1 (en)1996-06-142002-04-23Emisphere Technologies, Inc.Microencapsulated fragrances and method for preparation
US20050186176A1 (en)*1996-03-292005-08-25Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US20060134130A1 (en)*1993-04-222006-06-22Emisphere Technologies, Inc.Oral drug delivery compositions and methods
US20060166859A1 (en)*1997-02-072006-07-27Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US20080171907A1 (en)*2007-01-122008-07-17Ethicon Endo-Surgery, Inc.Magnetic Tissue Grasping

Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US1505209A (en)*1922-05-121924-08-19Francis I LeachRadium-carrying device
GB485378A (en)*1936-11-181938-05-18Johan Van RoojenImprovements in and relating to appliances for medical treatment with radiations from radio-active elements
US2483098A (en)*1946-01-091949-09-27Everett L MillardSupplying agents to the digestive tract
US2518758A (en)*1949-06-221950-08-15George B CookMagnetic stirring apparatus

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US1505209A (en)*1922-05-121924-08-19Francis I LeachRadium-carrying device
GB485378A (en)*1936-11-181938-05-18Johan Van RoojenImprovements in and relating to appliances for medical treatment with radiations from radio-active elements
US2483098A (en)*1946-01-091949-09-27Everett L MillardSupplying agents to the digestive tract
US2518758A (en)*1949-06-221950-08-15George B CookMagnetic stirring apparatus

Cited By (92)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2921584A (en)*1954-12-171960-01-19Honeywell Regulator CoVessel occluder
US3056724A (en)*1956-11-051962-10-02Commw Scient Ind Res OrgTherapeutic pellets for ruminants
US2971916A (en)*1957-01-301961-02-14Ncr CoMicroscopic capsules containing magnetizable material
US3118439A (en)*1957-04-091964-01-21Perrenoud Jean-PierreDiagnostic and medicating capsule and the method of use
US3057344A (en)*1957-05-211962-10-09Abella Carlos AlbertoCapsule for the study of the digestive tract and method of using the same
US2863458A (en)*1957-09-041958-12-09Michael T ModnyVein stripper and a method of stripping veins
US3042616A (en)*1958-08-261962-07-03IbmProcess of preparing magnetic ink
US3146169A (en)*1960-01-211964-08-25Burroughs Wellcome CoPharmaceutical formulations and their manufacture
US3421210A (en)*1964-08-051969-01-14Nitroglycerin AbMethod for the manufacture of the fuse head element of electric fuses
US3474777A (en)*1966-02-101969-10-28Amp IncMethod of administering therapeutic agents
US3592185A (en)*1967-04-181971-07-13Yeda Res & DevFerromagnetic contrast media and method of use
US3608549A (en)*1970-01-151971-09-28Merrill Edward WilsonMethod of administering drugs and capsule therefor
US4030499A (en)*1974-12-301977-06-21Louis BucaloMethod and apparatus for providing living beings with absorbable implants
US4162679A (en)*1976-09-281979-07-31Reenstierna Erik G BMethod and device for the implantation of one or more pacemaker electrodes in a heart
EP0000667A1 (en)*1977-08-011979-02-07Northwestern UniversityIntravascularly-administrable, magnetically-localizable biodegradable carrier and process for its preparation
US4247406A (en)*1979-04-231981-01-27Widder Kenneth JIntravascularly-administrable, magnetically-localizable biodegradable carrier
EP0042249A2 (en)1980-06-131981-12-23Northwestern UniversityMagnetically-localizable, biodegradable lipid microspheres
US4331654A (en)*1980-06-131982-05-25Eli Lilly And CompanyMagnetically-localizable, biodegradable lipid microspheres
US4878905A (en)*1986-02-071989-11-07Blass Karl GGastrointestinal module: a nonsurgical implant
USRE35862E (en)*1986-08-181998-07-28Emisphere Technologies, Inc.Delivery systems for pharmacological agents encapsulated with proteinoids
US5079006A (en)*1987-07-151992-01-07Aprex CorporationPharmaceutical compositions containing a magnetically detectable material
US4830855A (en)*1987-11-131989-05-16Landec Labs, Inc.Temperature-controlled active agent dispenser
EP0409893A4 (en)*1988-04-011991-03-13Walter Whitson FischmanMagnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
US5162037A (en)*1988-04-011992-11-10Whitson Laboratories, Inc.Magnetically influenced homeopathic pharmaceutical formulations, methods of their preparation and methods of their administration
US6071538A (en)*1992-06-152000-06-06Emisphere Technologies, Inc.Oral delivery composition comprising supramolecular complex
US6099856A (en)*1992-06-152000-08-08Emisphere Technologies, Inc.Active agent transport systems
US6413550B1 (en)1992-06-152002-07-02Emisphere Technologies, Inc.Proteinoid carriers and methods for preparation and use thereof
US5714167A (en)*1992-06-151998-02-03Emisphere Technologies, Inc.Active agent transport systems
US6348207B1 (en)1992-06-152002-02-19Emisiphere Technologies, Inc.Orally deliverable supramolecular complex
US5578323A (en)*1992-06-151996-11-26Emisphere Technologies, Inc.Proteinoid carriers and methods for preparation and use thereof
US5447728A (en)*1992-06-151995-09-05Emisphere Technologies, Inc.Desferrioxamine oral delivery system
US6245359B1 (en)1992-06-152001-06-12Emisphere Technologies, Inc.Active agent transport systems
US6221367B1 (en)1992-06-152001-04-24Emisphere Technologies, Inc.Active agent transport systems
US5601846A (en)*1992-06-151997-02-11Emisphere Technologies, Inc.Proteinoid microspheres and methods for preparation and use thereof
US5443841A (en)*1992-06-151995-08-22Emisphere Technologies, Inc.Proteinoid microspheres and methods for preparation and use thereof
US5811127A (en)*1992-06-151998-09-22Emisphere Technologies, Inc.Desferrioxamine oral delivery system
US5840340A (en)*1992-06-151998-11-24Emisphere Technologies, Inc.Proteinoid carriers and methods for preparation and use thereof
US5972387A (en)*1992-12-211999-10-26Emisphere Technologies, Inc.Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US5401516A (en)*1992-12-211995-03-28Emisphere Technologies, Inc.Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US5540939A (en)*1992-12-211996-07-30Emisphere Technologies, Inc.Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
US6100298A (en)*1993-04-222000-08-08Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5955503A (en)*1993-04-221999-09-21Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US20060134130A1 (en)*1993-04-222006-06-22Emisphere Technologies, Inc.Oral drug delivery compositions and methods
US5643957A (en)*1993-04-221997-07-01Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5709861A (en)*1993-04-221998-01-20Emisphere Technologies, Inc.Compositions for the delivery of antigens
US5958457A (en)*1993-04-221999-09-28Emisphere Technologies, Inc.Compositions for the delivery of antigens
US5766633A (en)*1993-04-221998-06-16Emisphere Technologies, Inc.Oral drug delivery compositions and methods
US5792451A (en)*1994-03-021998-08-11Emisphere Technologies, Inc.Oral drug delivery compositions and methods
EP0773005A1 (en)1994-03-181997-05-14Surgery Futures Research Inc.Magnetic operation table
US5593379A (en)*1994-03-181997-01-14Surgery Futures Research, Inc.Magnetic operating table
US5529568A (en)*1994-03-181996-06-25Surgery Futures Research, Inc.Magnetic operating table
US5629020A (en)*1994-04-221997-05-13Emisphere Technologies, Inc.Modified amino acids for drug delivery
US6180140B1 (en)1994-04-222001-01-30Emisphere Technologies, Inc.Modified amino acids for drug delivery
US5541155A (en)*1994-04-221996-07-30Emisphere Technologies, Inc.Acids and acid salts and their use in delivery systems
US5976569A (en)*1994-09-291999-11-02Emisphere Technologies, Inc.Diketopiperazine-based delivery systems
US5693338A (en)*1994-09-291997-12-02Emisphere Technologies, Inc.Diketopiperazine-based delivery systems
US6331318B1 (en)1994-09-302001-12-18Emisphere Technologies Inc.Carbon-substituted diketopiperazine delivery systems
US6346242B1 (en)1995-03-312002-02-12Emishpere Technologies, Inc.Compounds and compositions for delivering active agents
US6428780B2 (en)1995-03-312002-08-06Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5965121A (en)*1995-03-311999-10-12Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5989539A (en)*1995-03-311999-11-23Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5866536A (en)*1995-03-311999-02-02Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6001347A (en)*1995-03-311999-12-14Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6090958A (en)*1995-03-312000-07-18Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6071510A (en)*1995-03-312000-06-06Emisphere Technologies, Inc.Modified amino acids and compositions comprising the same for delivering active agents
US5650386A (en)*1995-03-311997-07-22Emisphere Technologies, Inc.Compositions for oral delivery of active agents
US5820881A (en)*1995-04-281998-10-13Emisphere Technologies, Inc.Microspheres of diamide-dicarboxylic acids
US5824345A (en)*1995-06-071998-10-20Emisphere Technologies, Inc.Fragrances and flavorants
US6051258A (en)*1995-06-072000-04-18Emisphere Technologies, Inc.Proteinoid emulsions and methods for preparation and use thereof
US5750147A (en)*1995-06-071998-05-12Emisphere Technologies, Inc.Method of solubilizing and encapsulating itraconazole
US6461545B1 (en)1995-06-072002-10-08Emisphere Technologies, Inc.Method of solubilizing and encapsulating itraconazole
US6100285A (en)*1995-06-072000-08-08Emisphere Technologies, Inc.Method of solubilizing itraconazole
US5667806A (en)*1995-06-071997-09-16Emisphere Technologies, Inc.Spray drying method and apparatus
US6084112A (en)*1995-09-112000-07-04Emisphere Technologies, Inc.Method for preparing ω-aminoalkanoic acid derivatives from cycloalkanones
US20050186176A1 (en)*1996-03-292005-08-25Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US7417022B2 (en)1996-03-292008-08-26Mhr Institutional Partners Iia LpCompounds and compositions for delivering active agents
US6375983B1 (en)1996-06-142002-04-23Emisphere Technologies, Inc.Microencapsulated fragrances and method for preparation
US5939381A (en)*1997-02-071999-08-17Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6060513A (en)*1997-02-072000-05-09Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5876710A (en)*1997-02-071999-03-02Emisphere Technologies Inc.Compounds and compositions for delivering active agents
US8686154B2 (en)1997-02-072014-04-01Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5804688A (en)*1997-02-071998-09-08Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5879681A (en)*1997-02-071999-03-09Emisphere Technolgies Inc.Compounds and compositions for delivering active agents
US5990166A (en)*1997-02-071999-11-23Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6242495B1 (en)1997-02-072001-06-05Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US20090324540A1 (en)*1997-02-072009-12-31Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US20060166859A1 (en)*1997-02-072006-07-27Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US7553872B2 (en)1997-02-072009-06-30Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US6313088B1 (en)1997-02-072001-11-06Emisphere Technologies, Inc.8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
US5863944A (en)*1997-04-301999-01-26Emisphere Technologies, Inc.Compounds and compositions for delivering active agents
US5962710A (en)*1997-05-091999-10-05Emisphere Technologies, Inc.Method of preparing salicyloylamino acids
US20080171907A1 (en)*2007-01-122008-07-17Ethicon Endo-Surgery, Inc.Magnetic Tissue Grasping

Similar Documents

PublicationPublication DateTitle
US2671451A (en)Remedial pill
ATE125445T1 (en) ORAL COMPOSITION FOR THE TREATMENT OF INTESTINAL INFLAMMATORY DISEASES.
SellingMen against madness.
Fielding et al.Peptic ulceration in Crohn's disease (regional enteritis)
Morinaga et al.Multiple primary cancers following exposure to benzidine and beta‐naphthylamine
Gambrell Jr et al.Changes in sexual drives of patients on oral contraceptives
DuttaBilateral parietal thinning in bronze age skull
GibberdDyspepsia in patients with rheumatoid arthritis
Brown et al.STD control in less developed countries: the time is now
FloridiWondrous Healings in Greek Epigrams (and Their Parodic Counterparts)
Davies et al.Goitre and hypothyroidism developing during treatment with PAS
BE895861A (en) THERAPEUTIC AGENT FOR THE TREATMENT OF ALLERGIC DISORDERS, IMMUNE COMPLEX DISEASES AND TUMORS
Heath et al.Arachnoid nodules in the lungs of high altitude Indians.
USD101664S (en)Design for a bkasslfire
HochmanManagement of Advanced Cancer in Israel
DaviesOn the Efficacy of Mercurial Action in Diseases
Gasbarrini et al.Pirenzepine in the treatment of benign gastroduodenal diseases. A double-blind controlled clinical trial
Gibson136pp.£ 9.99 (paper) The infinitesimal dose. The scientific roots of homoeopathy, Colin B. Lessell, CW Daniel, Oxford (1995), ISBN: 0 85207 276 7
USD166387S (en)Ven tor
Cade et al.Bolus obstruction
USD148559S (en)Design for a bracelet
USD167748S (en)hennessy
USD122443S (en)Design fob a brooch or similararticle
USD71220S (en)Tjbasabtjeo tomita
USD173459S (en)Sahlinhat

[8]ページ先頭

©2009-2025 Movatter.jp